Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practice management for ovulation induction.

L M Bonaventura1

  • 1Indianapolis Fertility Center, Inc., Indiana 46260.

The Journal of Reproductive Medicine
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

Human reproduction (Oxford, England)·1999
Same author

In vitro fertilization-embryo transfer and gamete intrafallopian transfer: Pregnancy Initiation Center, Indianapolis, Indiana.

Journal of in vitro fertilization and embryo transfer : IVF·1987
Same author

Tubal reanastomosis: a comparison between microsurgical and microlaser techniques.

Microsurgery·1987
Same author

The effect of aqueous progesterone on operative adhesion formation.

Fertility and sterility·1983
Same author

The effect of copper in vivo on specific progesterone binding by human endometrial cytosol.

Fertility and sterility·1979
Same author

The Sertoli cell in mixed gonadal dysgenesis.

Obstetrics and gynecology·1979

Fixed-dose Pergonal treatment resulted in a 59% pregnancy rate among 200 women. This study indicates the regimen is safe and effective for fertility treatment in private practice settings.

Area of Science:

  • Reproductive endocrinology and infertility treatment.

Background:

  • Pergonal (human menopausal gonadotropin) is a common treatment for infertility.
  • Optimizing dosage and monitoring protocols is crucial for maximizing efficacy and minimizing risks.

Purpose of the Study:

  • To evaluate the safety and effectiveness of a fixed dosage regimen of Pergonal.
  • To determine pregnancy rates and adverse event profiles associated with this treatment protocol.

Main Methods:

  • A prospective study involving 200 women undergoing fertility treatment.
  • Primary monitoring utilized vaginal ultrasonography to assess follicular development.
  • Pregnancy rates and outcomes including multiple births, hyperstimulation, spontaneous abortion, and ectopic pregnancy were recorded.

Main Results:

Related Experiment Videos

  • An overall pregnancy rate of 59% (118/200) was achieved.
  • Data on multiple births, hyperstimulation, spontaneous abortion, and ectopic pregnancy were collected and analyzed.

Conclusions:

  • Fixed-dose Pergonal administration, monitored by vaginal ultrasonography, is a safe and effective fertility treatment.
  • This regimen demonstrates favorable outcomes for women seeking conception in private practice settings.